AUS
NZ
UK
CA
USA
IND
Highlights
- Brambles posts steady returns with a strong dividend record
- Cochlear maintains robust growth in revenue and earnings
- Both stocks are standout performers among ASX200 stocks
Among the top-performing ASX200 stocks in 2025, Brambles (BXB) and Cochlear (COH) stand out for different reasons — one as a dividend-paying stalwart and the other as a consistent growth engine. Both companies offer insights into how established Australian businesses are adapting and excelling in the current economic landscape.
Brambles (ASX:BXB): A Foundation of Global Supply Chains
Brambles operates a unique and essential logistics model, managing the world’s largest pool of reusable pallets, crates, and containers. Through its well-known CHEP brand, it supports supply chains across the Asia-Pacific, Americas, Europe, the Middle East, and Africa.
The company charges daily hire fees as its pallets move between manufacturers and retailers. This ongoing revenue model has supported its resilience and growth. As of 2025, the Brambles share price is up 20.6% since the beginning of the year — a notable achievement for a mature business.
Brambles continues to appeal to those exploring ASX dividend stocks, with an average dividend yield of 2.7% over the past five years. Its FY24 results highlighted a solid return on equity (ROE) of 25.6% and a manageable debt/equity ratio of 81.8%, indicating financial stability with efficient capital usage.
Cochlear (ASX:COH): Delivering Growth with Purpose
Cochlear is a Sydney-based medical technology company that specializes in implantable hearing solutions. With more than 750,000 devices distributed globally, the company has built a strong reputation for transforming lives.
Unlike Brambles, Cochlear leans toward the growth spectrum. Over the last three years, Cochlear has achieved an annual revenue growth rate of 14.3%, reaching $2.24 billion in FY24. Its net profit rose from $324 million to $357 million during the same period. The company’s ROE stood at a healthy 19.9% — a figure that reflects efficient profit generation relative to shareholder equity.
Despite being 22.4% below its 52-week high, Cochlear’s long-term performance and expanding global footprint remain compelling for market watchers. It also represents a key contributor within the ASX200 stocks segment.
Brambles and Cochlear demonstrate the strength and diversity of the ASX200. With one offering consistent income and the other pursuing innovation-led growth, these companies reflect the multiple pathways to performance within Australia’s top listed firms. Whether it's income, stability, or expansion, these businesses highlight opportunities worth monitoring closely in 2025.
